Prophase Labs Stock Market Value
| PRPH Stock | USD 0.14 0.02 12.50% |
| Symbol | ProPhase |
Is there potential for Pharmaceuticals market expansion? Will ProPhase introduce new products? Factors like these will boost the valuation of ProPhase Labs. Anticipated expansion of ProPhase directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about ProPhase Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Earnings Share (19.80) | Revenue Per Share | Quarterly Revenue Growth (0.38) | Return On Assets |
The market value of ProPhase Labs is measured differently than its book value, which is the value of ProPhase that is recorded on the company's balance sheet. Investors also form their own opinion of ProPhase Labs' value that differs from its market value or its book value, called intrinsic value, which is ProPhase Labs' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because ProPhase Labs' market value can be influenced by many factors that don't directly affect ProPhase Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between ProPhase Labs' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ProPhase Labs should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, ProPhase Labs' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
ProPhase Labs 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ProPhase Labs' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ProPhase Labs.
| 11/09/2025 |
| 02/07/2026 |
If you would invest 0.00 in ProPhase Labs on November 9, 2025 and sell it all today you would earn a total of 0.00 from holding ProPhase Labs or generate 0.0% return on investment in ProPhase Labs over 90 days. ProPhase Labs is related to or competes with Cencora, Regeneron Pharmaceuticals, IDEXX Laboratories, Haleon Plc, Cigna Corp, Elevance Health, and Becton Dickinson. ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the cou... More
ProPhase Labs Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ProPhase Labs' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ProPhase Labs upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.36) | |||
| Maximum Drawdown | 77.27 | |||
| Value At Risk | (22.22) | |||
| Potential Upside | 11.11 |
ProPhase Labs Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ProPhase Labs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ProPhase Labs' standard deviation. In reality, there are many statistical measures that can use ProPhase Labs historical prices to predict the future ProPhase Labs' volatility.| Risk Adjusted Performance | (0.27) | |||
| Jensen Alpha | (3.98) | |||
| Total Risk Alpha | (5.32) | |||
| Treynor Ratio | 1.92 |
ProPhase Labs February 7, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.27) | |||
| Market Risk Adjusted Performance | 1.93 | |||
| Mean Deviation | 8.01 | |||
| Coefficient Of Variation | (286.03) | |||
| Standard Deviation | 11.84 | |||
| Variance | 140.15 | |||
| Information Ratio | (0.36) | |||
| Jensen Alpha | (3.98) | |||
| Total Risk Alpha | (5.32) | |||
| Treynor Ratio | 1.92 | |||
| Maximum Drawdown | 77.27 | |||
| Value At Risk | (22.22) | |||
| Potential Upside | 11.11 | |||
| Skewness | 1.31 | |||
| Kurtosis | 6.13 |
ProPhase Labs Backtested Returns
ProPhase Labs maintains Sharpe Ratio (i.e., Efficiency) of -0.33, which implies the firm had a -0.33 % return per unit of risk over the last 3 months. ProPhase Labs exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check ProPhase Labs' Coefficient Of Variation of (286.03), risk adjusted performance of (0.27), and Variance of 140.15 to confirm the risk estimate we provide. The company holds a Beta of -2.17, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning ProPhase Labs are expected to decrease by larger amounts. On the other hand, during market turmoil, ProPhase Labs is expected to outperform it. At this point, ProPhase Labs has a negative expected return of -4.07%. Please make sure to check ProPhase Labs' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if ProPhase Labs performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.83 |
Very good predictability
ProPhase Labs has very good predictability. Overlapping area represents the amount of predictability between ProPhase Labs time series from 9th of November 2025 to 24th of December 2025 and 24th of December 2025 to 7th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ProPhase Labs price movement. The serial correlation of 0.83 indicates that around 83.0% of current ProPhase Labs price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.83 | |
| Spearman Rank Test | 0.72 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out ProPhase Labs Correlation, ProPhase Labs Volatility and ProPhase Labs Performance module to complement your research on ProPhase Labs. For more detail on how to invest in ProPhase Stock please use our How to Invest in ProPhase Labs guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
ProPhase Labs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.